-
Loading metrics
Open Access
Peer-reviewed
Research Article
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
-
Antonio Giordano ,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: giordana@musc.edu
Affiliation Department of Medicine, Division of Hematology & Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Yueying Liu,
Roles Data curation, Formal analysis, Methodology, Software, Writing – original draft, Writing – review & editing
Affiliation Department of Medicine, Division of Hematology & Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Kent Armeson,
Roles Data curation, Formal analysis, Funding acquisition, Software, Validation, Writing – review & editing
Affiliation Department of Public Health Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Yeonhee Park,
Roles Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing
Affiliation Department of Public Health Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Maya Ridinger,
Roles Methodology, Resources, Writing – review & editing
Affiliation Trovagene Oncology, San Diego, California, United States of America
⨯ -
Mark Erlander,
Roles Resources, Writing – review & editing
Affiliation Trovagene Oncology, San Diego, California, United States of America
⨯ -
James Reuben,
Roles Methodology, Writing – review & editing
Affiliation Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Carolyn Britten,
Roles Funding acquisition, Resources, Supervision, Writing – review & editing
Affiliation Department of Medicine, Division of Hematology & Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Christiana Kappler,
Roles Formal analysis, Methodology, Validation, Writing – review & editing
Affiliation Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Elizabeth Yeh,
Roles Methodology, Resources, Supervision, Writing – review & editing
Affiliation Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indianapolis, United States of America
⨯ -
Stephen Ethier
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
- Antonio Giordano,
- Yueying Liu,
- Kent Armeson,
- Yeonhee Park,
- Maya Ridinger,
- Mark Erlander,
- James Reuben,
- Carolyn Britten,
- Christiana Kappler,
- Elizabeth Yeh
- Published: November 21, 2019
- https://doi.org/10.1371/journal.pone.0224420